Reversal of advanced renal dysfunction on bortezomib treatment in multiple myeloma patients.

被引：0
|
作者：
Mohrbacher, A [1 ]
Levine, AM [1 ]
机构：
[1] Univ So Calif, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：612S / 612S
页数：1
相关论文
共 50 条
  • [1] The Effect of Bortezomib on Renal Dysfunction in African American Patients with Multiple Myeloma
    Brar, Gagandeep
    Chintala, Parimal
    Catlett, Joseph Patrick
    Shenoy, Aarthi
    [J]. BLOOD, 2017, 130
  • [2] Reversal of acute renal failure by bortezomib-based chemotherapy in patients with multiple myeloma
    Ludwig, Heinz
    Drach, Johannes
    Graf, Helmut
    Lang, Alois
    Meran, Johannes Gobertus
    [J]. HAEMATOLOGICA, 2007, 92 (10) : 1411 - 1414
  • [3] Bendamustine and prednisone in combination with bortezomib in the treatment of patients with advanced multiple myeloma
    Poenisch, W.
    Bourgeois, M.
    Wang, S.
    Jaekel, N.
    Heyn, S.
    Braunert, L.
    Rohrberg, R.
    Hurtz, H.
    Hoffmann, F.
    Schwarzer, A.
    Becker, C.
    Al Ali, H.
    Niederwieser, D.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 171 - 171
  • [4] Bortezomib for the treatment of multiple myeloma patients
    Green, C.
    Bryant, J.
    Takeda, A.
    Cooper, K.
    Clegg, A.
    Smith, A.
    Stephens, M.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 : 29 - 33
  • [5] Treatment of patients with multiple myeloma complicated by renal failure with bortezomib - Based regimens
    Roussou, Maria
    Kastritis, Efstathios
    Anagnostopoulos, Athanasios
    Psimenou, Erasinia
    Grapsa, Irini
    Matsouka, Charis
    Barmparousi, Despina
    Terpos, Evangelos
    Dimopoulos, Meletios Athanasios
    [J]. BLOOD, 2007, 110 (11) : 805A - 805A
  • [6] Anti-angiogenic effect of bortezomib in multiple myeloma patients.
    Politou, M
    Naresh, K
    Terpos, E
    Crowley, D
    Lambert, I
    Apperley, JF
    Rahemtulla, A
    [J]. BLOOD, 2004, 104 (11) : 310B - 310B
  • [7] Efficacy and Safety of Once Weekly Bortezomib In Multiple Myeloma Patients.
    Bringhen, Sara
    Larocca, Alessandra
    Rossi, Davide
    Romano, Alessandra
    Genuardi, Mariella
    Ria, Roberto
    Leoni, Pietro
    Patriarca, Francesca
    Nozzoli, Chiara
    Guglielmelli, Tommasina
    Benevolo, Giulia
    Callea, Vincenzo
    Gentilini, Fabiana
    Elice, Francesca
    Olivero, Barbara
    Grasso, Mariella
    Falcone, Antonietta Pia
    Gottardi, Daniela
    Montefusco, Vittorio
    Allegra, Alessandro
    Rizzo, Manuela
    Leonardi, Giovanna
    Oddolo, Daniela
    Morabito, Fortunato
    Boccadoro, Mario
    Palumbo, Antonio
    [J]. BLOOD, 2010, 116 (21) : 1248 - 1249
  • [8] Response to bortezomib (BOR) and bone metabolism in multiple myeloma patients.
    Zangari, M
    Esseltine, DL
    Najarian, K
    Elice, F
    Lee, CK
    Yaccoby, S
    Thertulien, R
    Barlogie, B
    Tricot, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 569S - 569S
  • [9] EFFECTS OF BORTEZOMIB ON RENAL IMPAIRMENT MULTIPLE MYELOMA PATIENTS
    Chen, W.
    Lu, J.
    Hou, J.
    [J]. HAEMATOLOGICA, 2013, 98 : 340 - 341
  • [10] Bortezomib and dexamethasone in previously untreated multiple myeloma associated with renal failure and reversal of renal failure
    Malani, Ashok Kumar
    Gupta, Vicram
    Rangineni, Raj
    [J]. ACTA HAEMATOLOGICA, 2006, 116 (04) : 255 - 258
12345